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In 2012, the National Department of Health (DoH) adopted the 
National Contraception and Fertility Planning Policy. The overarching 
goal of this policy was to expand the country’s contraceptive 
method mix by promoting long-acting reversible contraceptive 
(LARC) methods, such as the subdermal contraceptive implant.[1] 
The policy narrative states that injectable contraceptives account for 
half of contraceptive use nationally and for up to 90% in some areas,[1] 
and that this predominance of short-term methods has several 
drawbacks. Many women discontinue injectable methods, or return 
late for their next injection,[1,2] placing them at risk for unintended 
pregnancy. Introducing the Implanon NXT, a long-acting subdermal 
contraceptive implant, in the public sector in 2014, thus aimed to 
provide a more effective contraceptive alternative.[3] Contraceptive 
implants, such as Implanon NXT, which offers 3 years of protection 
against pregnancy, are highly effective and acceptable across multiple 
settings.[4,5] 
In the year after the launch of Implanon NXT, the DoH reported 
that ~800 000 implants had been inserted and that >6 000 healthcare 
providers had been trained with regard to implant provision (T Zulu. 
Updates on the implant roll-out in South Africa: National perspective 
– unpublished paper presented at a meeting, Pretoria 2015). The DoH 
stated that by April 2015, according to their estimates, ~5 000 remo vals 
had been recorded and that this figure has been steadily rising over time. 
The DoH, however, was increasingly concerned following negative 
media reports on the implant and District Health Information 
System (DHIS) data showing a steady decline in uptake. Aside from 
a case report, where a woman in South Africa (SA) had the implant 
removed owing to bleeding irregularities 10 months after insertion, 
and unconfirmed estimates from the DoH, the actual number of 
and reasons for implant removals are unknown. These gaps in data 
signal weaknesses in monitoring systems in the family planning 
programme. 
When new contraceptive methods are introduced, there may 
be delays in incorporating indicators for use and safety within 
existing information systems.[7] The analysis of monitoring data 
from new methods, such as the implant in SA, therefore needs to 
be supplemented by the findings of periodic evaluations, and more 
rigorous, independent assessments of specific aspects of the services, 
such as the quality of the routine monitoring systems. We therefore 
examined the data management and record-keeping systems used 
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Background. Implanon NXT, a long-acting subdermal contraceptive implant, was introduced in South Africa (SA) in early 2014 as part 
of an expanded contraceptive method mix. After initial high levels of uptake, reports emerged of frequent early removals and declines in 
use. Monitoring of progress and challenges in implant service delivery could identify aspects of the programme that require strengthening. 
Objectives. To assess data management and record keeping within implant services at primary care facilities.
Methods. We developed a checklist to assess the tools used for monitoring implant services and data reporting to district offices. The 
checklist was piloted in seven facilities. An additional six high-volume and six low-volume implant insertion clinics in the City of 
Johannesburg (CoJ), Gauteng Province, and the Dr Kenneth Kaunda District, North West Province, were selected for assessment.
Results. All 12 facilities completed a Daily Head Count Register, which tallied the number of clients attending the clinic, but not information 
about implant use. A more detailed Tick Register recorded services that clinic attendees received, with nine documenting number of 
implant insertions and six implant removals. A more specific tool, an Insertion Checklist, collected data on insertion procedures and client 
characteristics, but was only used in CoJ (five of six facilities). Other registers, which were developed de novo by staff at individual facilities, 
captured more detailed information about insertions and removals, including reasons. Five of six low-volume insertion facilities used these 
registers, but only three of six high-volume facilities. No facilities used the form specifically developed by the National Department of Health 
for implant pharmacovigilance. Nine of 12 clinics reported data on numbers of insertions to the district office, six reported removals and 
none provided data on reasons for removals. 
Conclusion. For data to inform effective decision-making and quality improvement in implant services in SA, standardised reporting 
guidelines and data collection tools are needed, reinforced by staff training and quality assessment of data collection. Staff often took the 
initiative to fill gaps in reporting systems. Current systems are unable to accurately monitor uptake or discontinuation, or identify aspects of 
services requiring strengthening. Lack of pharmacovigilance data is especially concerning. Deficiencies noted in these monitoring systems 
may be common to family planning services more broadly, which warrants investigation. 
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to monitor implant insertions and removals in two districts of 
SA, focusing on their quality and standardisation across facilities. 
Identifying and addressing gaps in these systems will enable the 
DoH and other stakeholders to monitor whether the goals of implant 
services are being achieved, and to identify aspects of the services 
that require strengthening as per the process (Fig. 1). These findings 
may also inform decisions around the selection of indicators for the 
programme and the design of data collection tools.
Methods 
Study setting
This study, conducted in late 2016, formed one component of a larger 
evaluation in which we assessed the quality of implant services in SA. 
We selected six facilities in the City of Johannesburg (CoJ), Gauteng 
Province, and six in the Dr Kenneth Kaunda District (DKKD), 
North West Province. Sites were chosen based on the number of 
implant insertions recorded in the DHIS for 2015. The sampling 
frame for selecting the study sites in CoJ consisted of 17 primary 
care facilities, with a total of 1 045 insertions in 2015; the sites in 
DKKD were chosen from 40 facilities, with a total of 727 insertions. 
In each district, three facilities with the highest and three with the 
lowest number of insertions were included. High-volume clinics had 
inserted as many as 305 devices in CoJ in 2015, while all three in 
DKKD had inserted ~60. In both districts, most of the low-volume 
clinics had performed fewer than five insertions. All the selected 
facilities had been providing the implant since February 2014. 
Development and piloting of a checklist tool
We developed a study checklist to assess the presence and content 
of monitoring tools for recording and reporting data on the implant 
at primary care level. The tool was designed in consultation with a 
clinician, who had trained healthcare providers regarding the implant 
and was familiar with the services in SA and elsewhere. The checklist 
was then piloted in seven primary health facilities (three in CoJ and 
four in DKKD – distinct from the study sites) in late 2015. Facilities 
for the pilot were also selected based on the number of insertions 
done (three high- and four low-volume clinics). The research team 
used the pilot checklist to review the tools used to monitor implant 
use and the mechanisms for reporting of data to district offices, and 
finalised the tool thereafter. 
The final study checklist documented the presence of the tools 
(captured as a binary variable: present or not), purpose of five data 
collection tools that had been identified during the pilot, and vari-
ables collected in each (Table 1). The tool also assessed the reporting 
of statistics from facility to district level. 
Audit of monitoring tools in the study sites 
During site visits, using the study checklist, the study team reviewed 
the tools used for monitoring of implant services (any tool used from 
February 2014 onwards). In addition, family planning providers and 
clinic data capturers were asked about which data were reported to 
the district and the frequency of reporting. We present data using 
descriptive statistics for overall totals and for each district, and 
examine differences between high- and low-volume facilities.
Ethical approval
The study was approved by the University of the Witwatersrand 
Human Research Ethics Committee (ref. no. M151147). 
Results 
Data collection tools used for all facility attendees
All facilities have a Daily Reception Headcount Register, a standardised 
tool that was well established and maintained across all the facilities 
(Fig. 2). Although all clinics had a Primary Healthcare (PHC) 
Comprehensive Tick Register, different versions were being used in 
the two districts. The facilities in CoJ used the most updated version 
of the register, which included a section for recording both implant 
insertions and removals. DKKD facilities used an older version, which 
only records insertions. Overall, however, based on our observations, 
in only nine of the 12 facilities were data on insertions actually being 
captured in the PHC Comprehensive Tick Register, even though these 
registers included implant insertion fields in all clinics. Assessment 
of the Reception Headcount and PHC Tick registers during the pilot 
phase showed similar findings.
1. Data management and 
record keeping of implant 
services at facilities
2. Data reporting 
to district
3. Monitoring of performance
 and safety of implant 
services
4. Evaluation of implant 
services, including 
monitoring systems*
5. Strengthening of services
based on monitoring and 
evaluation data
Fig. 1. A monitoring and evaluation framework for implant services in South 
Africa. (*Evaluation of monitoring systems reported here was one component 
of a larger evaluation of implant services.)
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Fig. 2. Data collection tools for capturing implant insertion and removal 
data, and reporting of data to district level at six facilities in the City of 
Johannesburg and six in Dr Kenneth Kaunda District. (PHC = primary 
healthcare.)
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Data collection tools used only for implant insertions 
and removals
The Implant Insertion Checklist had been created specifically 
for the CoJ and was present in all six facilities in the district, but 
only used in five of them. No facilities in DKKD were using this 
or a similar checklist. However, in eight facilities (four in CoJ, 
four in DKKD), facility-based nurses had, on their own initiative, 
developed an Insertion and Removal Register to capture detailed 
data on implant insertions and removals. These consisted of either 
A4 sheets of paper or A5 books. While all eight of these entered data 
on insertions, only six collected data on removals. These registers 
were also noted at several of the clinics visited during the pilot 
phase of the study. 
The ‘home-made’ Insertion and Removal registers collected 
considerably more detailed information on insertions and removals 
than the other registers. The variables collected varied across 
facilities, but included data on name of provider who did the 
insertion, date of expected return following insertion, date of 
removal, reason for removal and name of provider who removed 
the device. The tools also often contained data that could be used 
to identify aspects of the services that require further attention or 
investigation. For example, data in one removal register showed that 
the implant had been removed in 14 clients who had presented with 
a broken implant. In these cases, which occurred over the course 
of a year, the broken devices had been discarded and the cases not 
communicated to the district or national level DoH. 
None of the 12 facilities was completing the Active Surveillance 
Reporting Form for Sub-Dermal Implant, and none of the staff was 
aware of the form’s existence. Similarly, none of the seven sites in the 
pilot study was using this form. 
Overall, 10 of the 12 facilities provided information to the district 
offices on the number of insertions done and nine reported removal 
numbers. No facilities reported the reasons for implant removals, or 
adverse events associated or potentially associated with the device. 
Differences in monitoring of implant insertions and 
removals between high- and low-volume facilities
Recording of insertions in the PHC Comprehensive Tick Register was 
similar between high-volume (5/6) and low-volume (4/6) facilities 
(Fig. 3). Recording of removals in the PHC Comprehensive Tick 
Register was done in all three high-volume and three low-volume 
facilities in CoJ, and none in DKKD. However, more low-volume 
inserting facilities (5/6) were using implant insertion registers than 
high-volume inserting facilities (3/6). Half the high-volume and 
half the low-volume inserting facilities used the implant removal 
register. All the high-volume facilities reported insertion statistics to 
the district, compared with only four of the six low-volume facilities. 
More high-volume facilities (6/6) reported removal statistics to the 
Table 1. Purpose, description and variables collected in data collection tools identified in the pilot study
Name of data collection 
tool identified in pilot* Purpose of tool Description of tool and variables collected
Daily Reception Headcount 
Register
To register all clients 
accessing the facility
Developed by DoH and nationally standardised. Documents the names, contact 
details and locator information of all clients attending PHC, including implant 
initiators, but does not specify reason for attendance
PHC Comprehensive Tick 
Register
To document visits to PHC 
services
Can be used to trace clients 
who have had an implant 
inserted 
Captures number of clients attending different services at a PHC. Includes client 
name and services that they receive. Contains a woman’s health section, capturing 
data on implant insertions and removals
Absolute numbers of clients utilising services are tallied and reported as part of 
the District Health Information System
Client contact details can be found by linking data with the Reception Headcount 
Register
Implant Insertion Checklist To gather information on 
implant insertions and 
characteristics of implant 
users
To provide concise 
instructions to health 
providers on how to insert an 
implant 
Developed by CoJ, to be completed for each implant insertion
Contains date of insertion and client information, e.g. name, client file number, 
date of birth and contact details
Captures reproductive history (i.e. parity, cervical cancer screening, breast cancer 
history and vaginal bleeding)
Contains concise instructions on how to insert an implant
Implant Insertion and 
Removal Register 
To capture detailed client 
information on insertion 
and removal, in addition to 
monitoring absolute numbers 
thereof 
Register or book that records implant insertions and detailed data on reasons for 
removals. Data collected extends beyond that of the PHC Comprehensive Tick 
Sheet, which records only absolute numbers of clients. Tools developed de novo 
by individual facilities 
Registers either combine insertion and removal data, or separate registers are used 
for insertions and removals
Active Surveillance 
Reporting Form for 
Subdermal Implants
Developed by DoH to track 
contraception use, medical 
history and adverse events 
related to implant use
A nationally prescribed form for capturing pharmacovigilance data exclusively 
for the implant. Variables to be collected include anthropometric measures; 
concomitant medications for TB, HIV and epilepsy, and herbal products; 
laboratory results (pregnancy test, haemoglobin, CD4 cell count, HIV viral load); 
reproductive health history (parity, breastfeeding, contraception use and cervical 
cancer screening); content of implant counselling; insertion and removal date; 
reason for removal; and any adverse drug reactions 
PHC = primary healthcare; DoH = Department of Health; CoJ = City of Johannesburg; TB = tuberculosis. 
*The five tools were identified at one or more of the pilot study sites. Variables collected in each tool are italicised.
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district using the PHC Comprehensive Tick Register and removal 
register as source data compared with half of the low-volume facili-
ties (3/6). 
Discussion
The study shows major gaps in tools and standardisation of monitoring 
systems for implant services. Data are not systematically reported to 
district level, e.g. a quarter of facilities do not submit numbers of 
removals. Overall, gaps in data collection and reporting, even in 
high-volume clinics, mean that the current DHIS underestimates 
the actual utilisation of the implant and give little indication of 
the occurrence (and timing) of removals. The South Africa Family 
Planning programme is therefore unable to understand the true 
extent of and reasons for the decline in implant use. Importantly, 
more high- than low-inserting facilities were reporting both insertion 
and removal statistics to the district. Data are not available to guide 
the initiatives that are urgently needed to strengthen implant services 
in the country.[8] This is especially pressing given the importance 
of robust data for directing service delivery in the first years after 
the introduction of contraceptive methods.[9] Problems with new 
methods, if not corrected, often lead to withdrawal of methods from 
national programmes.[10] 
The World Health Organization (WHO) framework for the 
introduction of new contraceptive methods suggests a three-stage 
process, which starts with determining a need for the new method 
according to end-user needs (Stage 1), conducting service delivery 
and end-user research (Stage 2), and exploring implications of 
research for utilisation of the method (Stage 3).[9] As per Stage 1, the 
DoH introduced the implant, recognising the need for an expanded 
method mix and methods that were not user dependent. This study 
addresses both Stage 2 (service-delivery research, monitoring in this 
instance) and Stage 3 (implications of assessment of monitoring for 
implant programmes). Poorly functioning monitoring systems hinder 
efforts of Stage 2 and compromise any efforts to strengthen services 
in Stage 3. 
The Policy Project suggests that a performance-monitoring sys-
tem should not be developed in a vacuum, but rather constitute an 
integral part of the overall service delivery system that is capable of 
identifying problems and taking corrective actions.[7] Traditionally, 
too much emphasis has been placed on mere recording of new 
acceptors of contraception, without consideration of other perti-
nent information, such as method continuation and reasons for 
discontinuation,[7] as noted in this study. Additional data sources, 
such as a repeat of this evaluation, may be needed in a few years 
to assess improvements in monitoring systems and other gaps in 
programming.[11] 
Furthermore, there is a need for disaggregated data on implant 
insertions and removals, such as by age and whether women are new 
contraceptive users or method switchers. DHIS data are sourced from 
the PHC Tick Register, which as a monitoring tool is constrained by 
the limited data it gathers, which does not include age, for example. It 
is, however, encouraging that the PHC Tick Register has evolved over 
time, with later versions encompassing data on removals, although 
these were not yet being used in DKKD. Seemingly, deficiencies 
in the data collection tools were apparent to health providers, who 
themselves then developed data collection tools to capture pertinent 
information. This demonstrates consi derable initiative and resource-
fulness of nurses, and illustrates their awareness of the importance of 
data collection. Even though these data are useful for the purposes of 
fine-tuning services at individual facilities, standardising data collec-
tion and reporting across clinics could alter district and even national 
programming. 
Commodity use does not appear to be captured in the DHIS for 
the implant, which should show numbers of devices ordered and 
returned, analogous to how antiretroviral drugs are monitored. 
Antiretroviral stocks are monitored by the DoH at drug depots and 
facility level. Stock delivered to individual facilities is also captured, 
and stock ordering and returns are accounted for at drug depots. The 
Handbook of Indicators for Family Planning Program Evaluation,[12] 
developed through the Evaluation Project, suggests that to measure 
service delivery operations, commodities need to be monitored. 
They suggest tracking quantities of contraceptives procured annually, 
quantities in stock at central stores, amount distributed from central 
stores, and inventory levels and stock-outs at service-delivery points. 
These data could complement facility-level reporting, and together 
provide useful insights to inform the fine-tuning, reorientation and 
planning of service improvements.
Of particular concern is that adverse events and other aspects of 
pharmacovigilance of the implant are not being collected. Removals, 
but also insertions, can have complications, which should be brought 
to the attention of district and provincial authorities. Even though 
complications are rare, a review of clinical studies of Implanon NXT 
showed that complications occur in ~1% of insertions.[13] These 
included deep insertions with fibrous adhesions, and non-palpable 
or broken implants.[13] The Active Surveillance Form for Sub-Dermal 
Implants has not been rolled out to the facilities, possibly as the 
number of data points it contains (24 variables) makes its comple-
tion onerous for health providers. If the purpose of this form is solely 
pharmacovigilance, fewer and more relevant indicators need to be 
selected and the form should be used.
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data, and reporting to district level in six high-volume and six low-volume 
clinics. (PHC = primary healthcare.)
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Study limitations
The study is limited by not having examined the quality and 
completeness of the data. Furthermore, the findings may not reflect the 
monitoring systems in the entire country, or of clinics that perform a 
moderate number of insertions. The generalisability of the findings are, 
however, enhanced by the inclusion of 19 sites (seven pilot study sites 
and 12 study sites) across two provinces, encompassing both urban and 
peri-urban locations. Also, sampling of both high- and low-volume 
clinics allowed for more detailed analysis of data systems. 
Conclusion 
This study is the first assessment of data management and reporting 
structures for monitoring the contraceptive implant in SA. The 
findings highlight aspects of the monitoring system that need 
to be strengthened to provide timely, actionable information to 
guide improvements in the country’s implant services. Our study 
underscores the need for standardised tools, and data collection and 
reporting guidelines. A single nationally standardised data collection 
tool could be developed, which consolidates and replaces the insertion 
checklist, insertion and removal registers, and pharmacovigilance 
forms. This could facilitate collection of data for a few carefully 
selected indicators of performance and obstacles to service delivery. 
Indicators need to be carefully considered and prioritised, so as to 
collect sufficiently detailed information, but without overburdening 
healthcare providers.[7] Clearly, data monitoring needs to extend 
beyond absolute counts of utilisation and discontinuation, which 
themselves are currently poorly collected. Other important data 
include client characteristics (especially age and most recent 
contraception), insertion and removal dates, reasons for removals, 
details of removal procedures (e.g. duration of the procedure and 
complications) and contraception choice after removal. As an 
immediate step, the reporting of data from the PHC Tick Register 
could be strengthened, and encompass insertions, removals and 
reasons for removal. Lastly, it is possible that deficiencies noted in 
this study are common to family planning services in SA in general, 
a concern that warrants further investigation. 
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